CIK 0000887359
- Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- Operating
- EIN
- 943096597
- Phone
- +1 617-588-5555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2006-05-12 | Hock Janet Mary VP Global Research & CSO | Option exercise | +46,875 | $1.05 | $49K | 74,275 |
| 2006-05-12 | Hock Janet Mary VP Global Research & CSO | Sale | −2,200 | $1.38 | $3K | 72,075 |
| 2006-05-12 | Hock Janet Mary VP Global Research & CSO | Sale | −23,700 | $1.36 | $32K | 48,375 |
| 2006-05-12 | Hock Janet Mary VP Global Research & CSO | Sale | −11,239 | $1.35 | $15K | 37,136 |
| 2006-05-12 | Hock Janet Mary VP Global Research & CSO | Option exercise · Employee Stock Option (Right to Buy) | −46,875 | $1.05 | $49K | 103,125 |
| 2005-09-20 | Hock Janet Mary VP Global Research | Grant or award | +27,400 | 27,400 | ||
| 2004-11-10 | Hock Janet Mary Vice President Global Research | Grant or award · Stock Option (right to buy) | +150,000 | $1.05 | $158K | 0 |
Page 1 of 1 · 7 trades